Dr. Himabindu Gaddipati is a practicing Oncologist in San Diego, CA. After graduating from Andhra Medical College, Visakhapatnam in 1999 she pursued 8 years of post-graduate training at University of Virginia in the United States. She completed Internal Medicine residency followed by post-doc fellowships in Genetics and Molecular Biology from the University of Pennsylvania, PA and Hematology/Oncology from University Hospitals/Case Western Reserve University. She served as a visiting scientist at the Wistar Research Institute. She was subsequently trained as an Interagency Taskforce Oncology Product Development post-doc fellow at the National Cancer Institute, Bethesda and The Food and Drug Administration (FDA).

She gained valuable insight about the regulatory requirements for marketing approval of drugs in the division of oncology at the FDA. At the National Cancer Institute, she served as an analyst for the Federal Small Business Innovation Research (SBIR Program) and also completed a certificate program in Technology Transfer. She also obtained a solid overview about the process of technology commercialization at the Wharton School of Business where she completed her Master’s Degree. She is currently the co-chairperson  for the Biocom oncology group, a network of more than 120 organizations including hospitals, research institutions, companies and foundations engaged in cancer related activities in the Southern California.